Friday, 20 April 2018 - 19:30
  • it
  • de
  • en
  • fr

Tobira Therapeutics

NASH: new results from Allergan’s drug

Allergan announced new data from the CENTAUR Phase IIb study which supports the anti-fibrotic efficacy and safety of Cenicriviroc (CVC) for the treatment of liver fibrosis in adults with NASH. The results from a one-year treatment with cenicriviroc were released…